Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection

BACKGROUND: Chronic antibody-mediated rejection (CABMR) is an important cause of late graft loss. De novo donor-specific antibody (dnDSA) is an important prognostic factor for long-term allograft outcomes. However, the prognosis of CABMR based on the presence of dnDSA is uncertain. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Woo Yeong, Kim, Yaerim, Paek, Jin Hyuk, Jin, Kyubok, Han, Seungyeup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Transplantation 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235340/
https://www.ncbi.nlm.nih.gov/pubmed/35769616
http://dx.doi.org/10.4285/kjt.20.0052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235340/
https://www.ncbi.nlm.nih.gov/pubmed/35769616
http://dx.doi.org/10.4285/kjt.20.0052

Ejemplares similares